Advertisement
Screener

Ascendis Pharma A/S (ASND) Revenue

2.8 / 5 stars · 68/120 Roast Me

Ascendis Pharma A/S Revenue

Ascendis Pharma A/S (ASND) reported Revenue of EUR 720.13 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.

Financial Statements › Income Statement › Other Income

ifrs-full:Revenue · last filed 2026-02-11

  • Ascendis Pharma A/S revenue for the quarter ending 2025-12-31 was 247.50M EUR, a 42.31% increase year-over-year.
  • Ascendis Pharma A/S revenue for the quarter ending 2025-09-30 was 213.63M EUR, a 269.40% increase year-over-year.
  • Ascendis Pharma A/S revenue for the quarter ending 2025-06-30 was 158.04M EUR, a 339.04% increase year-over-year.
  • Ascendis Pharma A/S revenue for the quarter ending 2025-03-31 was 100.95M EUR, a 5.28% increase year-over-year.
Period endRevenue 3 monthRevenue 6 monthRevenue 9 monthRevenue 12 month
2025-12-31247.50M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11
461.13M EUR
derived: sum of 2 quarters · filed 2026-02-11
619.18M EUR
derived: sum of 3 quarters · filed 2026-02-11
720.13M EUR
20-F · filed 2026-02-11
2025-09-30213.63M EUR
6-K · filed 2025-11-12
371.68M EUR
derived: sum of 2 quarters · filed 2025-11-12
472.63M EUR
6-K · filed 2025-11-12
646.55M EUR
derived: sum of 4 quarters · filed 2026-02-11
2025-06-30158.04M EUR
6-K · filed 2025-08-07
259.00M EUR
6-K · filed 2025-08-07
432.92M EUR
derived: sum of 3 quarters · filed 2026-02-11
490.75M EUR
derived: sum of 4 quarters · filed 2026-02-11
2025-03-31100.95M EUR
6-K · filed 2025-05-01
274.87M EUR
derived: sum of 2 quarters · filed 2026-02-11
332.70M EUR
derived: sum of 3 quarters · filed 2026-02-11
368.70M EUR
derived: sum of 4 quarters · filed 2026-02-11
2024-12-31173.92M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11
231.75M EUR
derived: sum of 2 quarters · filed 2026-02-11
267.75M EUR
derived: sum of 3 quarters · filed 2026-02-11
363.64M EUR
20-F · filed 2026-02-11
2024-09-3057.83M EUR
6-K · filed 2025-11-12
93.83M EUR
derived: sum of 2 quarters · filed 2025-11-12
189.72M EUR
6-K · filed 2025-11-12
327.43M EUR
derived: sum of 4 quarters · filed 2026-02-11
2024-06-3036.00M EUR
6-K · filed 2025-08-07
131.89M EUR
6-K · filed 2025-08-07
269.59M EUR
derived: sum of 3 quarters · filed 2026-02-11
317.63M EUR
derived: sum of 4 quarters · filed 2026-02-11
2024-03-3195.89M EUR
6-K · filed 2025-05-01
233.60M EUR
derived: sum of 2 quarters · filed 2026-02-11
281.63M EUR
derived: sum of 3 quarters · filed 2026-02-11
329.02M EUR
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31137.70M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11
185.74M EUR
derived: sum of 2 quarters · filed 2026-02-11
233.13M EUR
derived: sum of 3 quarters · filed 2026-02-11
266.72M EUR
20-F · filed 2026-02-11
2023-09-3048.03M EUR
6-K · filed 2024-11-14
95.43M EUR
derived: sum of 2 quarters · filed 2024-11-14
129.02M EUR
6-K · filed 2024-11-14
151.91M EUR
derived: sum of 4 quarters · filed 2025-02-12
2023-06-3047.39M EUR
6-K · filed 2024-09-03
80.98M EUR
6-K · filed 2024-09-03
103.88M EUR
derived: sum of 3 quarters · filed 2025-02-12
119.17M EUR
derived: sum of 4 quarters · filed 2025-02-12
2023-03-3133.59M EUR
6-K · filed 2024-05-02
56.48M EUR
derived: sum of 2 quarters · filed 2025-02-12
71.78M EUR
derived: sum of 3 quarters · filed 2025-02-12
77.94M EUR
derived: sum of 4 quarters · filed 2025-02-12
2022-12-3122.90M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12
38.19M EUR
derived: sum of 2 quarters · filed 2025-02-12
44.35M EUR
derived: sum of 3 quarters · filed 2025-02-12
51.17M EUR
20-F · filed 2025-02-12
2022-09-3015.29M EUR
6-K · filed 2023-11-07
21.45M EUR
derived: sum of 2 quarters · filed 2023-11-07
28.28M EUR
6-K · filed 2023-11-07
33.17M EUR
derived: sum of 4 quarters · filed 2024-02-07
2022-06-306.16M EUR
6-K · filed 2023-09-05
12.99M EUR
6-K · filed 2023-09-05
17.89M EUR
derived: sum of 3 quarters · filed 2024-02-07
19.00M EUR
derived: sum of 4 quarters · filed 2024-02-07
2022-03-316.83M EUR
6-K · filed 2023-04-27
11.72M EUR
derived: sum of 2 quarters · filed 2024-02-07
12.84M EUR
derived: sum of 3 quarters · filed 2024-02-07
13.86M EUR
derived: sum of 4 quarters · filed 2024-02-07
2021-12-314.90M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07
6.01M EUR
derived: sum of 2 quarters · filed 2024-02-07
7.03M EUR
derived: sum of 3 quarters · filed 2024-02-07
7.78M EUR
20-F · filed 2024-02-07
2021-09-301.11M EUR
6-K · filed 2022-11-02
2.13M EUR
derived: sum of 2 quarters · filed 2022-11-02
2.88M EUR
6-K · filed 2022-11-02
3.42M EUR
derived: sum of 4 quarters · filed 2023-02-16
2021-06-301.02M EUR
6-K · filed 2022-08-10
1.77M EUR
6-K · filed 2022-08-10
2.30M EUR
derived: sum of 3 quarters · filed 2023-02-16
5.06M EUR
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31746.00K EUR
6-K · filed 2022-05-11
1.28M EUR
derived: sum of 2 quarters · filed 2023-02-16
4.04M EUR
derived: sum of 3 quarters · filed 2023-02-16
5.47M EUR
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31535.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16
3.29M EUR
derived: sum of 2 quarters · filed 2023-02-16
4.73M EUR
derived: sum of 3 quarters · filed 2023-02-16
6.95M EUR
20-F · filed 2023-02-16
2020-09-302.76M EUR
6-K · filed 2021-11-10
4.19M EUR
derived: sum of 2 quarters · filed 2021-11-10
6.42M EUR
6-K · filed 2021-11-10
8.93M EUR
derived: sum of 4 quarters · filed 2022-03-02
2020-06-301.44M EUR
6-K · filed 2021-08-27
3.66M EUR
6-K · filed 2021-08-27
6.17M EUR
derived: sum of 3 quarters · filed 2022-03-02
8.41M EUR
derived: sum of 4 quarters · filed 2022-03-02
2020-03-312.23M EUR
6-K · filed 2021-05-27
4.73M EUR
derived: sum of 2 quarters · filed 2022-03-02
6.97M EUR
derived: sum of 3 quarters · filed 2022-03-02
10.19M EUR
derived: sum of 4 quarters · filed 2022-03-02
2019-12-312.51M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02
4.75M EUR
derived: sum of 2 quarters · filed 2022-03-02
7.96M EUR
derived: sum of 3 quarters · filed 2022-03-02
13.38M EUR
20-F · filed 2022-03-02
2019-09-302.24M EUR
6-K · filed 2020-11-12
5.45M EUR
derived: sum of 2 quarters · filed 2020-11-12
10.87M EUR
6-K · filed 2020-11-12
21.38M EUR
derived: sum of 4 quarters · filed 2021-03-10
2019-06-303.21M EUR
6-K · filed 2020-08-27
8.63M EUR
6-K · filed 2020-08-27
19.14M EUR
derived: sum of 3 quarters · filed 2021-03-10
19.16M EUR
derived: sum of 4 quarters · filed 2021-03-10
2019-03-315.41M EUR
6-K · filed 2020-05-19
15.93M EUR
derived: sum of 2 quarters · filed 2021-03-10
15.95M EUR
derived: sum of 3 quarters · filed 2021-03-10
15.97M EUR
derived: sum of 4 quarters · filed 2021-03-10
2018-12-3110.52M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10
10.54M EUR
derived: sum of 2 quarters · filed 2021-03-10
10.55M EUR
derived: sum of 3 quarters · filed 2021-03-10
10.58M EUR
20-F · filed 2021-03-10
2018-09-3020.00K EUR
6-K · filed 2019-11-18
38.00K EUR
derived: sum of 2 quarters · filed 2019-11-18
66.00K EUR
6-K · filed 2019-11-18
346.00K EUR
derived: sum of 4 quarters · filed 2020-04-03
2018-06-3018.00K EUR
6-K · filed 2019-08-28
46.00K EUR
6-K · filed 2019-08-28
326.00K EUR
derived: sum of 3 quarters · filed 2020-04-03
760.00K EUR
derived: sum of 4 quarters · filed 2020-04-03
2018-03-3128.00K EUR
6-K · filed 2019-05-30
308.00K EUR
derived: sum of 2 quarters · filed 2020-04-03
742.00K EUR
derived: sum of 3 quarters · filed 2020-04-03
1.19M EUR
derived: sum of 4 quarters · filed 2020-04-03
2017-12-31280.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03
714.00K EUR
derived: sum of 2 quarters · filed 2020-04-03
1.16M EUR
derived: sum of 3 quarters · filed 2020-04-03
1.53M EUR
20-F · filed 2020-04-03
2017-09-30434.00K EUR
6-K · filed 2018-11-28
878.00K EUR
derived: sum of 2 quarters · filed 2018-11-28
1.25M EUR
6-K · filed 2018-11-28
2017-06-30444.00K EUR
6-K · filed 2018-08-29
816.00K EUR
6-K · filed 2018-08-29
2017-03-31372.00K EUR
6-K · filed 2018-05-30
2016-12-314.61M EUR
20-F · filed 2019-04-03
2015-12-318.12M EUR
20-F · filed 2018-03-28